Jan Adolfsson

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2024;331(17):1460-1470
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
Martin RM; Turner EL; Young GJ; Metcalfe C; Walsh EI; Lane JA; Sterne JAC; Noble S; Holding P; Ben-Shlomo Y; Williams NJ; Pashayan N; Bui MN; Albertsen PC; Seibert TM; Zietman AL; Oxley J; Adolfsson J; Mason MD; Davey Smith G; Neal DE; Hamdy FC; Donovan JL
Article: BRITISH JOURNAL OF CANCER. 2023;128(5):814-824
Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
Lin E; Garmo H; Hagstrom E; Van Hemelrijck M; Adolfsson J; Stattin P; Zethelius B; Crawley D
Article: JOURNAL OF ONCOLOGY. 2023;2023:9527920-7
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.
George G; Garmo H; Adolfsson J; Elf K; Gedeborg R; Holmberg L; Stattin P; Styrke J; Van Hemelrijck M
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2023;154:197-203
The GIN-McMaster guideline tool extension for the integration of quality improvement and quality assurance in guidelines: a description of the methods for its development
Piggott T; Langendam MW; Parmelli E; Adolfsson J; Akl EA; Armstrong D; Braithwaite J; Brignardello-Petersen R; Brozek J; Follmann M; Kopp I; Meerpohl JJ; Neamtiu L; Nothacker M; Qaseem A; Rossi PG; Saz-Parkinson Z; van der Wees PJ; Schunemann HJ
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;44:46-51
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
Ventimiglia E; Bill-Axelson A; Adolfsson J; Aly M; Eklund M; Westerberg M; Stattin P; Garmo H
Article: BJU INTERNATIONAL. 2022;130(3):370-380
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
Lane JA; Donovan JL; Young GJ; Davis M; Walsh EI; Avery KNL; Blazeby JM; Mason MD; Martin RM; Peters TJ; Turner EL; Wade J; Bollina P; Catto JWF; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Neal DE; Hamdy FC; Metcalfe C
Article: JAMA NETWORK OPEN. 2022;5(8):e2225600
Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
Lin E; Garmo H; Van Hemelrijck M; Zethelius B; Stattin P; Hagstrom E; Adolfsson J; Crawley D
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(3):169-175
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
Bonde TM; Westerberg M; Aly M; Eklund M; Adolfsson J; Bill-Axelson A; Garmo H; Stattin P; Robinson D
Article: BJUI COMPASS. 2022;3(2):173-183
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohort
Khoshkar Y; Westerberg M; Adolfsson J; Bill-Axelson A; Olsson H; Eklund M; Akre O; Garmo H; Aly M
Article: BMC CANCER. 2021;21(1):1259
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
Lin E; Garmo H; Van Hemelrijck M; Adolfsson J; Stattin P; Zethelius B; Crawley D
Article: BMC HEALTH SERVICES RESEARCH. 2021;21(1):172
Bringing two worlds closer together: a critical analysis of an integrated approach to guideline development and quality assurance schemes
Piggott T; Langendam M; Parmelli E; Adolfsson J; Akl EA; Armstrong D; Braithwaite J; Brignardello-Petersen R; Brozek J; Gore-Booth J; Follmann M; Les Z; Meerpohl JJ; Neamtiu L; Nothacker M; Qaseem A; Rossi PG; Saz-Parkinson Z; van der Wees P; Schuenemann HJ
Article: BMC HEALTH SERVICES RESEARCH. 2021;21(1):173
Guideline-based quality assurance: a conceptual framework for the definition of key elements
Parmelli E; Langendam M; Piggott T; Adolfsson J; Akl EA; Armstrong D; Braithwaite J; Brignardello-Petersen R; Follmann M; Les Z; Meerpohl JJ; Neamtiu L; Qaseem A; Rossi PG; Saz-Parkinson Z; van der Wees PJ; Schuenemann HJ
Article: EUROPEAN UROLOGY OPEN SCIENCE. 2021;24:43-51
The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects
Koitsalu M; Eklund M; Adolfsson J; Sprangers MAG; Gronberg H; Brandberg Y
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2020;23(3):527-533
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Beckmann K; Garmo H; Lindahl B; Holmberg L; Stattin P; Adolfsson J; Cruickshank JK; Van Hemelrijck M
Article: EUROPEAN UROLOGY. 2020;77(3):320-330
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
Neal DE; Metcalfe C; Donovan JL; Lane JA; Davis M; Young GJ; Dutton SJ; Walsh EI; Martin RM; Peters TJ; Turner EL; Mason M; Bryant R; Bollina P; Catto J; Doherty A; Gillatt D; Gnanapragasam V; Holding P; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Altman DG; Hamdy FC; Doble A; Powell P; Prescott S; Rosario D; Anderson JB; Aning J; Durkan G; Koupparis A; Leung H; Mariappan P; McNeill A; Persad R; Schwaibold H; Tulloch D; Wallace M; Bonnington S; Bradshaw L; Cooper D; Elliott E; Herbert P; Howson J; Jones A; Lennon T; Lyons N; Moody H; Plumb C; O'Sullivan T; Salter E; Thompson P; Tidball S; Blaikie J; Gray C; Adam T; Askew S; Atkinson S; Baynes T; Brain C; Breen V; Brunt S; Bryne S; Bythem J; Clarke J; Cloete J; Dark S; Davis G; De La Rue R; Denizot J; Dewhurst E; Dimes A; Dixon N; Ebbs P; Emmerson I; Ferguson J; Gadd A; Geoghegan L; Grant A; Grant C; Godfrey R; Goodwin L; Hall S; Hart L; Harvey A; Hoult C; Hawkins S; Holling S; Innes A; Kilner S; Marshall F; Mellen L; Moore A; Napier S; Needham J; Pearse K; Pisa A; Rees M; Richards E; Robson L; Roxburgh J; Samuel N; Sharkey I; Slater M; Smith D; Taggart P; Taylor H; Taylor V; Thomas A; Tomkies B; Trewick N; Ward C; Walker C; Williams A; Woodhouse C; Wyber E; Bahl A; Benson R; Beresford M; Ferguson C; Graham J; Herbert C; Howard G; James N; Kirkbride P; Law A; Loughrey C; McClaren D; Patterson H; Pedley I; Roberts T; Robinson A; Russell S; Symonds P; Thanvi N; Vasanthan S; Wilson P; Robinson JOM; Bhattarai S; Deshmukh N; Dormer J; Fernando M; Goepel J; Griffiths D; Grigor K; Mayer N; Varma M; Warren A; Appleby H; Ash D; Aston D; Bolton S; Chalmers G; Conway J; Early N; Geater T; Goddall L; Heymann C; Hicks D; Jones L; Lamb S; Lambert G; Lawrence G; Lewis G; Lilley J; MacLeod A; Massey P; McQueen A; Moore R; Penketh L; Potterton J; Roberts N; Showler H; Shuttleworth P; Slade S; Steele A; Swinscoe J; Tiffany M; Townley J; Treeby J; Weston M; Wilkinson J; Williams L; Wills L; Woodley O; Yarrow S; Brindle L; Davies L; Dedman D; Down E; Khazragui H; Noble S; Taylor H; Tazewell M; Wade J; Walsh E; Baker S; Bellis-Sheldon E; Bougard C; Bowtell J; Brewer C; Burton C; Charlton J; Christoforou N; Clark R; Coull S; Croker C; Currer R; Daisey C; Delaney G; Donohue R; Drew J; Farmer R; Fry S; Haddow J; Hale A; Halpin S; Harris B; Hattrick B; Holmes S; Hunt H; Jackson V; Johnson D; Le Butt M; Leworthy J; Liddiatt T; Martin A; Mauree J; Moore S; Moulam G; Mutch J; Parker K; Pawsey C; Purdie M; Robson T; Smith L; Stenton C; Steuart-Feilding T; Stott B; Sully C; Sutton C; Torrington C; Wilkins Z; Williams S; Wilson A; Weaver A; Albertsen P; Adolfsson J; Baum M; McFarlane J; Reid C; Robinson M; Turner E; Zietman A; Hill E; Ng SY; Williams N; Toole J; Davies C; Hughes L; Mari-Anne; Rowlands; Bell L; Harrison S; Mauree J; Grant A; Roberts I; Ashby D; Cowan R; Fayers P; Mellon K; N'Dow J; O'Brien T; Sokhal M; Dearnaley D; Schroder F; Roberts T
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(1):20-26
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden
George G; Garmo H; Rudman S; Holmberg L; Robinson D; Stattin P; Adolfsson J; Van Hemelrijck M
Article: FRONTIERS IN ONCOLOGY. 2020;10:571838
Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study
Parker J; Crawley D; Garmo H; Lindahl B; Styrke J; Adolfsson J; Lambe M; Stattin P; Van Hemelrijck M; Beckmann K
Article: JAMA NETWORK OPEN. 2019;2(11):e1914689
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
Beckmann K; Crawley D; Nordstrom T; Aly M; Olsson H; Lantz A; Abd Jalal NB; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
Article: EUROPEAN UROLOGY FOCUS. 2019;5(5):842-848
Poor Follow-up After Elevated Prostate-specific Antigen Tests: A Population-based Cohort Study
Aly M; Clements M; Weibull CE; Nordstrom T; Naslund E; Adolfsson J; Gronberg H
Article: EUROPEAN UROLOGY. 2019;76(3):276-279
The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers
Heijnsdijk EAM; Adolfsson J; Auvinen A; Roobol MJ; Hugosson J; de Koning HJ
Article: BMC UROLOGY. 2019;19(1):73
Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
Beckmann K; Kinsella N; Olsson H; Lantz AW; Nordstrom T; Aly M; Adolfsson J; Eklund M; Van Hemelrijck M
Article: BJU INTERNATIONAL. 2019;124(1):87-92
Androgen deprivation therapy for prostate cancer and risk of dementia
Robinson D; Garmo H; Van Hemelrijck M; Damber J-E; Bratt O; Holmberg L; Wahlund L-O; Stattin P; Adolfsson J
Article: BMC CANCER. 2019;19(1):612
Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
Beckmann K; Russell B; Josephs D; Garmo H; Haggstrom C; Holmberg L; Stattin P; Van Hemelrijck M; Adolfsson J
Article: EUROPEAN UROLOGY. 2019;75(4):676-683
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer
Beckmann K; Garmo H; Adolfsson J; Bosco C; Johansson E; Robinson D; Holmberg L; Stattin P; Van Hemelrijck M
Article: ACTA ONCOLOGICA. 2019;58(1):110-118
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study
Thomsen FB; Bosco C; Garmo H; Adolfsson J; Hammar N; Stattin P; Van Hemelrijck M
Article: EUROPEAN UROLOGY. 2018;74(6):722-728
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
Gronberg H; Eklund M; Picker W; Aly M; Jaderling F; Adolfsson J; Landquist M; Haug ES; Strom P; Carlsson S; Nordstrom T
Article: EUROPEAN UROLOGY FOCUS. 2018;4(5):707-710
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing
Eklund M; Nordstrom T; Aly M; Adolfsson J; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Presti JC; StLezin M; Clements M; Egevad L; Gronberg H
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2018;52(4):277-284
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden
Nugin H; Folkvaljon Y; Damber J-E; Adolfsson J; Robinson D; Stattin P
Article: NATURE COMMUNICATIONS. 2018;9(1):2256
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Al Olama AA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IMJ; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordstrom T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu Y-J; Zhang H-W; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gomez-Caamano A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castano-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin H-Y; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Roder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo S-H; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw K-T; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
Article: EUROPEAN UROLOGY FOCUS. 2018;4(3):385-387
Balancing Overdiagnosis and Early Detection of Prostate Cancer using the Stockholm-3 Model
Nordstrom T; Gronberg H; Adolfsson J; Egevad L; Aly M; Eklund M
Article: EUROPEAN UROLOGY. 2018;73(4):502-511
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy: A Nationwide Population-based Observational Study
Robinson D; Garmo H; Lissbrant IF; Widmark A; Pettersson A; Gunnlaugsson A; Adolfsson J; Bratt O; Nilsson P; Stattin P
Article: BMJ OPEN. 2018;8(3):e020787
Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Armes J; Holmberg L; Adolfsson J; Van Hemelrijck M
Article: BJU INTERNATIONAL. 2018;121(2):260-267
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists
Bosco C; Wong C; Garmo H; Crawley D; Holmberg L; Hammar N; Adolfsson J; Stattin P; Van Hemelrijck M
Article: BJU INTERNATIONAL. 2018;121(2):209-216
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2018;18(1):3
Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial
Koitsalu M; Eklund M; Adolfsson J; Gronberg H; Brandberg Y
Article: PLOS ONE. 2018;13(4):e0195690
A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
Russell B; Garmo H; Beckmann K; Stettin P; Adolfsson J; Van Hemelrijck M
Article: PLOS ONE. 2018;13(7):e0200409
Predictors of participation in risk-based prostate cancer screening
Koitsalu M; Eklund M; Adolfsson J; Sprangers MAG; Gronberg H; Brandberg Y
Article: EUROPEAN JOURNAL OF CANCER. 2018;88:101-108
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data
Lycken M; Drevin L; Garmo H; Stattin P; Adolfsson J; Lissbrant IF; Holmberg L; Bill-Axelson A
Article: EUROPEAN UROLOGY. 2017;72(6):920-928
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
Thomsen FB; Sandin F; Garmo H; Lissbrant IF; Ahlgren G; Van Hemelrijck M; Adolfsson J; Robinson D; Stattin P
Article: BMC UROLOGY. 2017;17(1):92
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
Nordstrom T; Adolfsson J; Gronberg H; Eklund M
Article: EUROPEAN UROLOGY. 2017;72(4):534-541
Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer
Van Hemelrijck M; Garmo H; Lindhagen L; Bratt O; Stattin P; Adolfsson J
Article: BRITISH JOURNAL OF CANCER. 2017;117(5):734-743
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
Lophatananon A; Stewart-Brown S; Kote-Jarai Z; Al Olama AA; Garcia SB; Neal DE; Hamdy FC; Donovan JL; Giles GG; Fitzgerald LM; Southey MC; Pharoah P; Pashayan N; Gronberg H; Wiklund F; Aly M; Stanford JL; Brenner H; Dieffenbach AK; Arndt V; Park JY; Lin H-Y; Sellers T; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; Easton D; Eeles RA; Muir K
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2017;45(3):230-237
Waiting times for cancer patients in Sweden: A nationwide population-based study
Robertson S; Adolfsson J; Stattin P; Sjovall A; Winnersjo R; Hanning M; Sandelin K
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017;97(5):1026-1031
Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
Bosco C; Garmo H; Adolfsson J; Stattin P; Holmberg L; Nilsson P; Gunnlaugsson A; Widmark A; Van Hemelrijck M
Article: PLOS ONE. 2017;12(8):e0182877
Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study
Lexomboon D; Karlsson P; Adolfsson J; Ekbom A; Naimi-Akbar A; Bahmanyar S; Montgomery S; Sandborgh-Englund G
Article: JOURNAL OF UROLOGY. 2017;197(1):61-66
Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study
Thorstenson A; Garmo H; Adolfsson J; Bratt O
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;139(12):2698-2704
Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
Crawley D; Garmo H; Rudman S; Stattin P; Haggstrom C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
Article: BJU INTERNATIONAL. 2016;118(6):869-879
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KNL; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2016;108(12):djw165
Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions
Nordstrom T; Adolfsson J; Gronberg H; Eklund M
Article: BRITISH JOURNAL OF CANCER. 2016;115(11):1400-1407
Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.
Colzani E; Clements M; Johansson ALV; Liljegren A; He W; Brand J; Adolfsson J; Fornander T; Hall P; Czene K
Article: LAKARTIDNINGEN. 2016;113:ECE4
Replik från Socialstyrelsen och SBU: - Kraven på opartiskhet och vetenskaplighet är höga.
Keller L; Adolfsson J; Larsson L-T; Hall C
Article: TRIALS. 2016;17(1):497
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
Walsh EI; Turner EL; Lane JA; Donovan JL; Neal DE; Hamdy FC; Martin RM; the CAP & ProtecT Trial Groups; Investigators; Research staff; Management Committee; CAP & ProtecT Trial Steering Committee; Data Monitoring Committee; Administrative staff
Article: CLINICAL ONCOLOGY. 2016;28(9):e92-e100
Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance
Mason MD; Moore R; Jones G; Lewis G; Donovan JL; Neal DE; Hamdy FC; Lane JA; Staffurth JN
Article: BJU INTERNATIONAL. 2016;118(3):391-398
Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
O'Farrell S; Sandstrom K; Garmo H; Stattin P; Holmberg L; Adolfsson J; Van Hemelrijck M
Article: BRITISH JOURNAL OF CANCER. 2016;115(1):90-94
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee
Turner EL; Metcalfe C; Donovan JL; Noble S; Sterne JAC; Lane JA; Walsh EI; Hill EM; Down L; Ben-Shlomo Y; Oliver SE; Evans S; Brindle P; Williams NJ; Hughes LJ; Davies CF; Ng SY; Neal DE; Hamdy FC; Albertsen P; Reid CM; Oxley J; McFarlane J; Robinson MC; Adolfsson J; Zietman A; Baum M; Koupparis A; Martin RM
Article: NATURE COMMUNICATIONS. 2016;7:10979
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Gusev A; Shi H; Kichaev G; Pomerantz M; Li F; Long HW; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Zheng W; Pettaway CA; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; John EM; Murphy AB; Signorello LB; Carpten J; Leske MC; Wu S-Y; Hennis AJM; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Witte JS; Casey G; Kaggwa S; Cook MB; Stram DO; Blot WJ; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Gronberg H; Wiklund F; Aly M; Henderson BE; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Teerlink C; Brenner H; Dieffenbach AK; Arndt V; Park JY; Sellers TA; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Spurdle A; Clements JA; Teixeira MR; Pandha H; Michael A; Paulo P; Maia S; Kierzek A; Conti DV; Albanes D; Berg C; Berndt SI; Campa D; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giovannucci E; Hoover R; Hunter DJ; Johansson M; Kraft P; Le Marchand L; Lindstrom S; Navarro C; Overvad K; Riboli E; Siddiq A; Stevens VL; Trichopoulos D; Vineis P; Yeager M; Trynka G; Raychaudhuri S; Schumacher FR; Price AL; Freedman ML; Haiman CA; Pasaniuc B; Cook M; Guy M; Govindasami K; Leongamornlert D; Sawyer EJ; Wilkinson R; Saunders EJ; Tymrakiewicz M; Dadaev T; Morgan A; Fisher C; Hazel S; Livni N; Lophatananon A; Pedersen J; Hopper JL; Adolfson J; Stattin P; Johansson J-E; Cavalli-Bjoerkman C; Karlsson A; Broms M; Auvinen A; Kujala P; Maeaettaenen L; Murtola T; Taari K; Weischer M; Nielsen SF; Klarskov P; Roder A; Iversen P; Wallinder H; Gustafsson S; Cox A; Brown P; George A; Marsden G; Lane A; Davis M; Zheng W; Signorello LB; Blot WJ; Tillmans L; Riska S; Wang L; Rinckleb A; Lubiski J; Stegmaier C; Pow-Sang J; Park H; Radlein S; Rincon M; Haley J; Zachariah B; Kachakova D; Popov E; Mitkova A; Vlahova A; Dikov T; Christova S; Heathcote P; Wood G; Malone G; Saunders P; Eckert A; Yeadon T; Kerr K; Collins A; Turner M; Srinivasan S; Kedda M-A; Alexander K; Omara T; Wu H; Henrique R; Pinto P; Santos J; Barros-Silva J
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2016;50(2):104-109
A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies
Nordstrom T; Bratt O; Ortegren J; Aly M; Adolfsson J; Gronberg H
Article: BJU INTERNATIONAL. 2016;117(3):507-514
Causes of death in men with localized prostate cancer: a nationwide, population-based study
Van Hemelrijck M; Folkvaljon Y; Adolfsson J; Akre O; Holmberg L; Garmo H; Stattin P
Article: BMJ SUPPORTIVE AND PALLIATIVE CARE. 2015;5(4):413-419
Quality indicators for palliative and end of life care: a review of Swedish policy documents
Lind S; Adolfsson J; Axelsson B; Furst CJ
Article: THE LANCET ONCOLOGY. 2015;16(16):1667-1676
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Gronberg H; Adolfsson J; Aly M; Nordstrom T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Article: CANCER CAUSES AND CONTROL. 2015;26(11):1603-1616
The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium
Davies NM; Gaunt TR; Lewis SJ; Holly J; Donovan JL; Hamdy FC; Kemp JP; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pashayan N; Khaw K-T; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; Lathrop M; Smith GD; Martin RM
Article: HUMAN MOLECULAR GENETICS. 2015;24(19):5589-5602
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans
Al Olama AA; Dadaev T; Hazelett DJ; Li Q; Leongamornlert D; Saunders EJ; Stephens S; Cieza-Borrella C; Whitmore I; Garcia SB; Giles GG; Southey MC; Fitzgerald L; Gronberg H; Wiklund F; Aly M; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; Mcdonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Arndt V; Park JY; Sellers T; Lin H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Govindasami K; Guy M; Lophatonanon A; Muir K; Vinuela A; Brown AA; Freedman M; Conti DV; Easton D; Coetzee GA; Eeles RA; Kote-Jarai Z
Article: PROSTATE. 2015;75(13):1467-1474
Prediction of Individual Genetic Risk to Prostate Cancer Using a Polygenic Score
Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TLJ; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw K-T; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubinski J; Kluzniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lim H-Y; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Gronberg H; Wiklund F
Article: JOURNAL OF CLINICAL ONCOLOGY. 2015;33(11):1243-1251
Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
O'Farrell S; Garmo H; Holmberg L; Adolfsson J; Stattin P; Van Hemelrijck M
Article: EUROPEAN JOURNAL OF CANCER. 2015;51(6):725-733
The risk of prostate cancer for men on aspirin, statin or antidiabetic medications
Nordstrom T; Clements M; Karlsson R; Adolfsson J; Gronberg H
Article: CANCER DISCOVERY. 2015;5(4):368-379
A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Stegeman S; Amankwah E; Klein K; O'Mara TA; Kim D; Lin H-Y; Permuth-Wey J; Sellers TA; Srinivasan S; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pharoah P; Khaw K-T; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Kaneva R; Teixeira MR; Spurdle AB; Clements JA; Park JY; Batra J
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2015;15:6
Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)
Williams NJ; Hill EM; Ng SY; Martin RM; Metcalfe C; Donovan JL; Evans S; Hughes LJ; Davies CF; Hamdy FC; Neal DE; Turner EL
Article: PLOS ONE. 2015;10(3):e0117344
Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
Bosco C; Crawley D; Adolfsson J; Rudman S; Van Hemelrijck M
Article: LAKARTIDNINGEN. 2014;111(48):2150-2151
[Specialist referral with photography for faster diagnosis of skin tumor. Management can be better planned--and saves resources].
Adolfsson J; Cedermark B; Terstappen K
Article: THE LANCET ONCOLOGY. 2014;15(10):1109-1118
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
Lane JA; Donovan JL; Davis M; Walsh E; Dedman D; Down L; Turner EL; Mason MD; Metcalfe C; Peters TJ; Neal DE; Hamdy FC
Article: EUROPEAN JOURNAL OF CANCER. 2014;50(10):1789-1798
Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study
Lycken M; Garmo H; Adolfsson J; Stattin P; Holmberg L; Bill-Axelson A
Article: JOURNAL OF UROLOGY. 2014;192(1):112-119
Rehospitalization after Radical Prostatectomy in a Nationwide, Population Based Study
Frioriksson JO; Holmberg E; Adolfsson J; Lambe M; Bill-Axelson A; Carlsson S; Hugosson J; Stattin P
Article: THE LANCET. 2014;383(9935):2127-2135
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
McGale P; Taylor C; Correa C; Cutter D; Duane F; Ewertz M; Gray R; Mannu G; Peto R; Whelan T; Wang Y; Wang Z; Darby S
Article: BREAST CANCER RESEARCH AND TREATMENT. 2014;145(2):471-480
Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics
Hajiebrahimi M; Cnattingius S; Lambe M; Hsieh C-C; Ahlgren J; Adolfsson J; Bahmanyar S
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2014;48(3):231-238
Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the National Swedish Kidney Cancer Register
Thorstenson A; Bergman M; Scherman-Plogell A-H; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Article: BRITISH JOURNAL OF CANCER. 2014;110(5):1378-1384
Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics
Colzani E; Johansson ALV; Liljegren A; Foukakis T; Clements M; Adolfsson J; Hall P; Czene K
Article: EUROPEAN UROLOGY. 2014;65(1):169-176
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Gronberg H; Wiklund F
Article: BJU INTERNATIONAL. 2013;112(8):1113-1120
Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients
van Hemelrijck M; Thorstenson A; Smith P; Adolfsson J; Akre O
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2013;42(4):956-967
Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
Van Hemelrijck M; Wigertz A; Sandin F; Garmo H; Hellstrom K; Fransson P; Widmark A; Lambe M; Adolfsson J; Varenhorst E; Johansson J-E; Stattin P
Article: ACTA ONCOLOGICA. 2013;52(5):919-932
Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000-2007
Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebo B; Pahlman L; Sjovall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP
Article: THORAX. 2013;68(6):551-564
Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007
Walters S; Maringe C; Coleman MP; Peake MD; Butler J; Young N; Bergstrom S; Hanna L; Jakobsen E; Kolbeck K; Sundstrom S; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Linklater KM; McGahan CE; Steward J; Tracey E; Turner D; Richards MA; Rachet B
Article: EUROPEAN JOURNAL OF CANCER. 2013;49(8):1984-1992
Differences in survival from prostate cancer in Denmark, Iceland and Sweden
Brasso K; Ingimarsdottir IJ; Rusch E; Engholm G; Adolfsson J; Tryggvadottir L; Jonsson E; Bill-Axelson A; Holmberg E; Storm HH
Article: EUROPEAN JOURNAL OF CANCER. 2013;49(7):1588-1599
Risk of suicide in men with low-risk prostate cancer
Carlsson S; Sandin F; Fall K; Lambe M; Adolfsson J; Stattin P; Bill-Axelson A
Article: NATURE GENETICS. 2013;45(4):385-391e2
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Eeles RA; Al Olama AA; Benlloch S; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Ghoussaini M; Luccarini C; Dennis J; Jugurnauth-Little S; Dadaev T; Neal DE; Hamdy FC; Donovan JL; Muir K; Giles GG; Severi G; Wiklund F; Gronberg H; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock SJ; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Canzian F; Riboli E; Key TJ; Travis RC; Campa D; Ingles SA; John EM; Hayes RB; Pharoah PDP; Pashayan N; Khaw K-T; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Vogel W; Kibel AS; Cybulski C; Lubhiski J; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Spurdle AB; Clements JA; Teixeira MR; Dicks E; Lee A; Dunning AM; Baynes C; Conroy D; Maranian MJ; Ahmed S; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As NJ; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatananon A; Cox A; Southey MC; Hopper JL; English DR; Aly M; Adolfsson J; Xu J; Zheng SL; Yeager M; Kaaks R; Diver WR; Gaudet MM; Stern MC; Corral R; Joshi AD; Shahabi A; Wahlfors T; Tammela TLJ; Auvinen A; Virtamo J; Klarskov P; Nordestgaard BG; Roder MA; Nielsen SF; Bojesen SE; Siddiq A; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Blot WJ; Zheng W; Cai Q; McDonnell SK; Rinckleb AE; Drake B; Colditz G; Wokolorczyk D; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Sellers TA; Lin H-Y; Slavov C; Mitev V; Lose F; Srinivasan S; Maia S; Paulo P; Lange E; Cooney KA; Antoniou AC; Vincent D; Bacot F; Tessier DC; Kote-Jarai Z; Easton DF
Article: BRITISH JOURNAL OF CANCER. 2013;108(5):1195-1208
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study
Walters S; Maringe C; Butler J; Rachet B; Barrett-Lee P; Bergh J; Boyages J; Christiansen P; Lee M; Waernberg F; Allemani C; Engholm G; Fornander T; Gjerstorff ML; Johannesen TB; Lawrence G; McGahan CE; Middleton R; Steward J; Tracey E; Turner D; Richards MA; Coleman MP
Article: CANCER CAUSES AND CONTROL. 2013;24(3):505-515
How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden
Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM-L; Dickman PW
Article: EUROPEAN UROLOGY. 2013;63(3):419-425
Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003-2011
Nordstrom T; Aly M; Clements MS; Weibull CE; Adolfsson J; Gronberg H
Article: EUROPEAN UROLOGY. 2013;63(2):354-363
Thromboembolic Events Following Surgery for Prostate Cancer
Van Hemelrijck M; Garmo H; Holmberg L; Bill-Axelson A; Carlsson S; Akre O; Stattin P; Adolfsson J
Article: HUMAN MOLECULAR GENETICS. 2013;22(2):408-415
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease
Al Olama AA; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TLJ; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Doerk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang H-W; Lu Y-J; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Roder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin H-Y; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao G-W; Slavov C; Mitev V; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
Article: PLOS ONE. 2013;8(9):e74492
Mortality following Hip Fracture in Men with Prostate Cancer
Van Hemelrijck M; Garmo H; Michaelsson K; Thorstenson A; Akre O; Stattin P; Holmberg L; Adolfsson J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;137(1):297-305
Placental weight and mortality in premenopausal breast cancer by tumor characteristics
Hajiebrahimi MH; Bahmanyar S; Lambe M; Adolfsson J; Fornander T; Waernberg F; Cnattingius S
Article: CANCER. 2012;118(24):6207-6216
Primary Cancers Before and After Prostate Cancer Diagnosis
Van Hemelrijck M; Drevin L; Holmberg L; Garmo H; Adolfsson J; Stattin P
Article: PUBLIC HEALTH NUTRITION. 2012;15(10):1897-1908
The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study
Moller E; Galeone C; Adami H-O; Adolfsson J; Andersson TM-L; Bellocco R; Gronberg H; Mucci LA; Balter K
Article: EUROPEAN UROLOGY. 2012;62(4):656-661
Concordance of Tumor Differentiation Among Brothers with Prostate Cancer
Jansson KF; Akre O; Garmo H; Bill-Axelson A; Adolfsson J; Stattin P; Bratt O
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(28):3478-3485
Tumor Stage Affects Risk and Prognosis of Contralateral Breast Cancer: Results From a Large Swedish-Population-Based Study
Vichapat V; Garmo H; Holmqvist M; Liljegren G; Warnberg F; Lambe M; Fornander T; Adolfsson J; Luechtenborg M; Holmberg L
Article: BREAST CANCER RESEARCH AND TREATMENT. 2012;135(1):281-289
Impact of comorbidity on management and mortality in women diagnosed with breast cancer
Berglund A; Wigertz A; Adolfsson J; Ahlgren J; Fornander T; Warnberg F; Lambe M
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(11):1672-1681
Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden
Thorstenson A; Bratt O; Akre O; Hellborg H; Holmberg L; Lambe M; Bill-Axelson A; Stattin P; Adolfsson J
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(7):949-960
Rare thoracic cancers, including peritoneum mesothelioma
Siesling S; van der Zwan JM; Izarzugaza I; Jaal J; Treasure T; Foschi R; Ricardi U; Groen H; Tavilla A; Ardanaz E
Article: BREAST CANCER RESEARCH AND TREATMENT. 2012;133(1):367-373
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
Wigertz A; Ahlgren J; Holmqvist M; Fornander T; Adolfsson J; Lindman H; Bergkvist L; Lambe M
Article: EUROPEAN UROLOGY. 2012;61(4):690-700
Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden
Van Hemelrijck M; Garmo H; Holmberg L; Stattin P; Adolfsson J
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(6):783-796
Rare cancers of the head and neck area in Europe
Van Dijk BAC; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(4):456-464
Incidence and survival of rare urogenital cancers in Europe
Visser O; Adolfsson J; Rossi S; Verne J; Gatta G; Maffezzini M; Franks KN
Article: THE LANCET. 2012;379(9814):432-444
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Albain K; Anderson S; Arriagada R; Barlow W; Bergh J; Bliss J; Buyse M; Cameron D; Carrasco E; Clarke M; Correa C; Coates A; Collins R; Costantino J; Cutter D; Cuzick J; Darby S; Davidson N; Davies C; Davies K; Delmestri A; Di Leo A; Dowsett M; Elphinstone P; Evans V; Ewertz M; Gelber R; Gettins L; Geyer C; Goldhirsch A; Godwin J; Gray R; Gregory C; Hayes D; Hill C; Ingle J; Jakesz R; James S; Kaufmann M; Kerr A; MacKinnon E; McGale P; McHugh T; Norton L; Ohashi Y; Paik S; Pan HC; Perez E; Peto R; Piccart M; Pierce L; Pritchard K; Pruneri G; Raina V; Ravdin P; Robertson J; Rutgers E; Shao YF; Swain S; Taylor C; Valagussa P; Viale G; Whelan T; Winer E; Wang Y; Wood W
Article: CANCER EPIDEMIOLOGY. 2012;36(1):e7-12
A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study
Holmberg L; Robinson D; Sandin F; Bray F; Linklater KM; Klint A; Lambert PC; Adolfsson J; Hamdy FC; Catto J; Moller H
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;130(2):478-487
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden
Robinson D; Garmo H; Lindahl B; Van Hemelrijck M; Adolfsson J; Bratt O; Holmberg L; Stattin P
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(1):75-84
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer
Berglund A; Garmo H; Robinson D; Tishelman C; Holmberg L; Bratt O; Adolfsson J; Stattin P; Lambe M
Article: EUROPEAN JOURNAL OF CANCER. 2012;48(2):159-169
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanaz E; Berrino F
Article: THE LANCET. 2011;378(9804):1707-1716
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
Article: BREAST CANCER RESEARCH AND TREATMENT. 2011;130(2):553-560
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden
Foukakis T; Fornander T; Lekberg T; Hellborg H; Adolfsson J; Bergh J
Article: EUROPEAN JOURNAL OF CANCER. 2011;47(17):2493-2511
Rare cancers are not so rare: The rare cancer burden in Europe
Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(30):4014-4021
Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics
Colzani E; Liljegren A; Johansson ALV; Adolfsson J; Hellborg H; Hall PFL; Czene K
Article: EUROPEAN UROLOGY. 2011;60(3):554-563
Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Article: EUROPEAN JOURNAL OF CANCER. 2011;47(14):2195-2201
Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe Sweden
Bill-Axelson A; Garmo H; Nyberg U; Lambe M; Bratt O; Stattin P; Adolfsson J; Steineck G
Article: THE LANCET ONCOLOGY. 2011;12(9):891-899
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial
Johansson E; Steineck G; Holmberg L; Johansson J-E; Nyberg T; Ruutu M; Bill-Axelson A
Article: THE LANCET. 2011;378(9793):771-784
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
Davies C; Godwin J; Gray R; Clarke M; Darby S; McGale P; Wang YC; Peto R; Pan HC; Cutter D; Taylor C; Ingle J
Article: RADIOTHERAPY AND ONCOLOGY. 2011;100(2):167-175
Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden
McGale P; Darby SC; Hall P; Adolfsson J; Bengtsson N-O; Bennet AM; Fornander T; Gigante B; Jensen M-B; Peto R; Rahimi K; Taylor CW; Ewertz M
Article: EUROPEAN UROLOGY. 2011;60(1):21-28
Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study
Aly M; Wiklund F; Xu J; Isaacs WB; Eklund M; D'Amato M; Adolfsson J; Gronberg H
Article: ACTA ONCOLOGICA. 2011;50(3):353-359
Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women
Vu HT; Tani E; Johansson H; Adolfsson J; Krawiec K; Ta TV; Skoog L
Article: PROSTATE. 2011;71(4):421-430
Inherited Genetic Markers Discovered to Date Are Able to Identify a Significant Number of Men at Considerably Elevated Risk for Prostate Cancer
Sun J; Kader AK; Hsu F-C; Kim S-T; Zhu Y; Turner AR; Jin T; Zhang Z; Adolfsson J; Wiklund F; Zheng SL; Isaacs WB; Gronberg H; Xu J
Article: THE LANCET. 2011;377(9760):127-138
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2010;44(6):384-390
Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: A population-based study from the National Prostate Cancer Register of Sweden
Bratt O; Berglund A; Adolfsson J; Johansson J-E; Tornblom M; Stattin P
Article: JOURNAL OF UROLOGY. 2010;184(4):1322-1327
Outcome of Primary Versus Deferred Radical Prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study
Holmstrom B; Holmberg E; Egevad L; Adolfsson J; Johansson J-E; Hugosson J; Stattin P
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2010;102(17):1336-1343
Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(21):3448-3456
Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden
Van Hemelrijck M; Garmo H; Holmberg L; Ingelsson E; Bratt O; Bill-Axelson A; Lambe M; Stattin P; Adolfsson J
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2010;102(13):950-958
Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
Stattin P; Holmberg E; Johansson J-E; Holmberg L; Adolfsson J; Hugosson J
Article: BREAST CANCER RESEARCH AND TREATMENT. 2010;121(3):679-683
Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years
Lambe M; Wigertz A; Holmqvist M; Adolfsson J; Bardage C; Fornander T; Karlsson P; Odlind V; Persson I; Ahlgren J; Bergkvist L
Article: THE LANCET ONCOLOGY. 2010;11(5):450-458
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
Van Hemelrijck M; Adolfsson J; Garmo H; Bill-Axelson A; Bratt O; Ingelsson E; Lambe M; Stattin P; Holmberg L
Article: EUROPEAN UROLOGY. 2010;57(3):446-452
Development of a New Method for Monitoring Prostate-Specific Antigen Changes in Men with Localised Prostate Cancer: A Comparison of Observational Cohorts
Tilling K; Garmo H; Metcalfe C; Holmberg L; Hamdy FC; Neal DE; Adolfsson J; Martin RM; Davis M; Fall K; Lane JA; Adami H-O; Bill-Axelson A; Johansson J-E; Donovan JL
Article: FOOD AND CHEMICAL TOXICOLOGY. 2010;48(3):820-824
Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data
Vikstrom AC; Wilson KM; Paulsson B; Athanassiadis I; Gronberg H; Adami H-O; Adolfsson J; Mucci LA; Balter K; Tornqvist M
Article: EUROPEAN UROLOGY. 2010;57(3):390-395
Suicide Risk in Men with Prostate-Specific Antigen-Detected Early Prostate Cancer: A Nationwide Population-Based Cohort Study from PCBaSe Sweden
Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(5):2136-2140
Inherited genetic variant predisposes to aggressive but not indolent prostate cancer
Xu J; Zheng SL; Isaacs SD; Wiley KE; Wiklund F; Sun J; Kader AK; Li G; Purcell LD; Kim S-T; Hsu F-C; Stattin P; Hugosson J; Adolfsson J; Walsh PC; Trent JM; Duggan D; Carpten J; Gronberg H; Isaacs WB
Article: BRITISH JOURNAL OF CANCER. 2009;101(6):902-907
Impact of tumour size on axillary involvement and distant dissemination in breast cancer
Koscielny S; Arriagada R; Adolfsson J; Fornander T; Bergh J
Article: CANCER CAUSES AND CONTROL. 2009;20(5):663-670
Season of diagnosis and prognosis in breast and prostate cancer
Holmberg L; Adolfsson J; Mucci L; Garmo H; Adami HO; Moeller H; Johansson J-E; Stampfer M
Article: HUMAN MOLECULAR GENETICS. 2009;18(7):1368-1375
Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk
Chang B-L; Cramer SD; Wiklund F; Isaacs SD; Stevens VL; Sun J; Smith S; Pruett K; Romero LM; Wiley KE; Kim S-T; Zhu Y; Zhang Z; Hsu F-C; Turner AR; Adolfsson J; Liu W; Kim JW; Duggan D; Carpten J; Zheng SL; Rodriguez C; Isaacs WB; Gronberg H; Xu J
Article: PROSTATE. 2009;69(4):419-427
Association of Reported Prostate Cancer Risk Alleles With PSA Levels Among Men Without a Diagnosis of Prostate Cancer
Wiklund F; Zheng SL; Sun J; Adami H-O; Lilja H; Hsu F-C; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang B-L; Isaacs WB; Gronberg H; Xu J
Article: CLINICAL CANCER RESEARCH. 2009;15(3):1105-1111
Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen
Zheng SL; Sun J; Wiklund F; Gao Z; Stattin P; Purcell LD; Adami H-O; Hsu F-C; Zhu Y; Adolfsson J; Johansson J-E; Turner AR; Adams TS; Li W; Duggan D; Carpten JD; Chang B-L; Isaacs WB; Xu J; Gronberg H
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2009;43(5):350-356
Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
Carlsson S; Adolfsson J; Bratt O; Johansson J-E; Ahlstrand C; Holmberg E; Stattin P; Hugosson J
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2009;43(5):342-349
PCBaSe Sweden: A register-based resource for prostate cancer research
Hagel E; Garmo H; Bill-Axelson A; Bratt O; Johansson J-E; Adolfsson J; Lambe M; Stattin P
Article: JOURNAL OF UROLOGY. 2008;180(6):2423-2429
Surveillance and Deferred Treatment for Localized Prostate Cancer. Population Based Study in the National Prostate Cancer Register of Sweden
Stattin P; Holmberg E; Bratt O; Adolfsson J; Johansson J-E; Hugosson J
Article: CLINICAL CANCER RESEARCH. 2008;14(20):6712-6716
Y Chromosome Haplotypes and Prostate Cancer in Sweden
Lindstrom S; Adami H-O; Adolfsson J; Wiklund F
Article: NATURE GENETICS. 2008;40(10):1153-1155
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12
Sun J; Zheng SL; Wiklund F; Isaacs SD; Purcell LD; Gao Z; Hsu F-C; Kim S-T; Liu W; Zhu Y; Stattin P; Adami H-O; Wiley KE; Dimitrov L; Sun J; Li T; Turner AR; Adams TS; Adolfsson J; Johansson J-E; Lowey J; Trock BJ; Partin AW; Walsh PC; Trent JM; Duggan D; Carpten J; Chang B-L; Gronberg H; Isaacs WB; Xu J
Article: EUROPEAN JOURNAL OF CANCER. 2008;44(5):733-739
Predictors for the symptomatic prostate cancer patient's delays in seeking care
Sunny L; Hopfgarten T; Adolfsson J; Steineck G
Article: EUROPEAN UROLOGY. 2007;52(4):1028-1035
The 20-yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: The prognostic value of tumour ploidy and comorbidity
Adolfsson J; Tribukait B; Levitt S
Article: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(27):4210-4216
Incidence and prognosis of synchronous and Metachronous bilateral breast cancer
Hartman M; Czene K; Reilly M; Adolfsson J; Bergh J; Adami H-O; Dickman PW; Hall P
Article: BJU INTERNATIONAL. 2007;99(6):1391-1397
Economic conditions and marriage quality of men with prostate cancer
Sunny L; Hopfgarten T; Adolfsson J; Steineck G
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2007;99(7):526-532
Prostate-specific antigen levels as a predictor of lethal prostate cancer
Fall K; Garmo H; Andren O; Bill-Axelson A; Adolfsson J; Adami H-O; Johansson J-E; Holmberg L
Article: INTERNATIONAL JOURNAL OF CANCER. 2007;120(2):398-405
Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism
Hedelin M; Chang ET; Wiklund F; Bellocco R; Klint A; Adolfsson J; Shahedi K; Xu J; Adami H-O; Gronberg H; Balter KA
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2007;41(6):456-477
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andren O; Bill-Axelson A; Bratt O; Damber J-E; Hellstrom K; Hellstrom M; Holmberg E; Holmberg L; Hugosson J; Johansson J-E; Petterson B; Tornblom M; Widmark A; Stattin P
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2007;41(5):367-374
The internet and prostate cancer patients searching for and finding information
Buntrock S; Hopfgarten T; Adolfsson J; Onelov E; Steineck G
Article: CANCER RESEARCH. 2006;66(22):11077-11083
Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-α-reductase type 2 is important for prostate cancer development
Lindstrom S; Wiklund F; Adami H-O; Balter KA; Adolfsson J; Gronberg H
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(3):668-672
Genetic variation in the COX-2 gene and the association with prostate cancer risk
Shahedi K; Lindstrom S; Zheng SL; Wiklund F; Adolfsson J; Sun J; Augustsson-Balter K; Chang B-L; Adami H-O; Liu W; Gronberg H; Xu J
Article: EUROPEAN UROLOGY. 2006;50(2):280-289
The choice between a therapy-induced long-term symptom and shortened survival due to prostate cancer
Hopfgarten T; Adolfsson J; Henningsohn L; Onelov E; Steineck G
Article: BJU INTERNATIONAL. 2006;97(4):847-851
A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder
Sakano S; Kumar R; Larsson P; Onelöv E; Adolfsson J; Steineck G; Hemminki K
Article: ACTA ONCOLOGICA. 2006;45(4):421-429
A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods
Steineck G; Hunt H; Adolfsson J
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2006;40(5):397-408
Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunction
Al-Abany M; Helgason AR; Adolfsson J; Steineck G
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2006;40(5):363-369
Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16^INK4a)/ARF (p14^ARF) locus in urinary bladder cancer
De Verdier PJB; Kumar R; Adolfsson J; Larsson P; Norming U; Onelov E; Wijkstrom H; Steineck G; Hemminki K
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2006;22(4):500-505
Disseminating evidence from health technology assessment: the case of tobacco prevention.
Axelsson S; Helgason AR; Lund KE; Adolfsson J
Article: HUMAN GENETICS. 2005;118(3-4):339-347
Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk:: strong confirmation of functional promoter SNP
Lindström S; Wiklund F; Jonsson BA; Adami HO; Bälter K; Brookes AJ; Xu JF; Zheng SL; Isaacs WB; Adolfsson J; Grönberg H
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2005;352(19):1977-1984
Radical prostatectomy versus watchful waiting in early prostate cancer
Bill-Axelson A; Holmberg L; Ruutu M; Häggman M; Andersson SO; Bratell S; Spångberg A; Busch C; Nordling S; Garmo H; Palmgren J; Adami HO; Norlén BJ; Johansson JE
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2005;39(2):117-123
The National Prostate Cancer Register in Sweden 1998-2002:: Trends in incidence, treatment and survival
Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2005;39(4):271-276
Need for and access to bereavement support after loss of a husband to urologic cancers:: a nationwide follow-up of Swedish widows
Valdimarsdóttir U; Helgason AR; Fürst CJ; Adolfsson J; Steineck G
Article: JOURNAL OF UROLOGY. 2004;172(6):2208-2212
Hip fractures in men with prostate cancer treated with orchiectomy
Dickman PW; Adolfsson J; Åström K; Steineck G
Article: CLINICAL CANCER RESEARCH. 2004;10(21):7150-7156
Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer
Wiklund F; Jonsson BA; Brookes AJ; Strömqvist L; Adolfsson J; Emanuelsson M; Adami HO; Augustsson-Bälter K; Grönberg H
Article: PALLIATIVE MEDICINE. 2004;18(5):432-443
Awareness of husband's impending death from cancer and long-term anxiety in widowhood:: a nationwide follow-up
Valdimarsdóttir U; Helgason AR; Fürst CJ; Adolfsson J; Steineck G
Article: BJU INTERNATIONAL. 2003;92:112-114
Monitoring the ERSPC trial
De Koning HJ; Hakulinen T; Moss SM; Adolfsson J; Smith PH; Alexander FE
Article: COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY. 2003;31(5):378-385
Tobacco prevention in Swedish dental care
Helgason AR; Lund KE; Adolfsson J; Axelsson S
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2003;37(3):195-201
A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years
Larsson P; Wijkström H; Thorstenson A; Adolfsson J; Norming U; Wiklund P; Onelöv E; Steineck G
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(1):98-103
Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene
Sakano S; Berggren P; Kumar R; Steineck G; Adolfsson J; Onelöv E; Hemminki K; Larsson P
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2003;37(2):106-111
Bladder neoplasms -: Regions at chromosome 9 with putative tumour suppressor genes
Wada T; Berggren P; Steineck G; Adolfsson J; Wijkström H; Norming U; Hansson J; Hernminkil K; Larsson P
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2003;31(1):31-36
Long-term effects of widowhood after terminal cancer:: a Swedish nationwide follow-up
Valdimarsdóttir U; Helgason AR; Fürst CJ; Adolfsson J; Steineck G
Article: CLINICAL CANCER RESEARCH. 2003;9(1):235-242
Detecting homozygous deletions in the CDKN2Ap16INK4αARF(p14ARF) gene in urinary bladder cancer using real-time quantitative PCR
Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
Article: PHARMACOECONOMICS (AUCKLAND). 2003;21(4):241-247
Health-related quality-of-life assessments in patients with advanced cancer of the prostate
Adolfsson J
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2002;347(11):790-796
Quality of life after radical prostatectomy or watchful waiting
Steineck G; Helgesen F; Adolfsson J; Dickman PW; Johansson J; Norlén BJ; Holmberg L
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2002;347(11):781-789
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer
Holmberg L; Bill-Axelson A; Helgesen F; Salo JO; Folmerz P; Häggman M; Andersson S; Spångberg A; Busch C; Nordling S; Palmgren J; Adami HO; Johansson J; Norlén BJ
Article: BRITISH JOURNAL OF CANCER. 2002;86(10):1540-1545
The unrecognised cost of cancer patients' unrelieved symptoms:: a nationwide follow-up of their surviving partners
Valdimarsdóttir U; Helgason AR; Fürst CJ; Adolfsson J; Steineck G
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2002;36(1):28-33
Treatment of patients with clinical T3 prostate cancer
Aus G; Adolfsson J; Selli C; Widmark A
Article: BJU INTERNATIONAL. 2001;87(9):876-881
The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction
Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Steineck G
Article: BRITISH JOURNAL OF CANCER. 2001;84(11):1505-1511
p53 mutations in urinary bladder cancer
Berggren P; Steineck G; Adolfsson J; Hansson J; Jansson O; Larsson P; Sandstedt B; Wijkström H; Hemminki K
Article: LAKARTIDNINGEN. 2001;98(8):798-802
[Fixation on randomization inhibits clinical therapeutic research].
Steineck G; Adolfsson J
Article: BRITISH JOURNAL OF CANCER. 2001;84(3):329-334
Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma
Seddighzadeh M; Steineck G; Jansson O; Larsson P; Wijkström H; Adolfsson J; Portwood N; Hansson J; Linder S
Article: JOURNAL OF UROLOGY. 2001;165(2):678-682
Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells
Morcos E; Jansson OT; Adolfsson J; Ehrén I; Wiklund NP
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2001;35(2):97-101
Emotional isolation. prevalence and the effect on wellbeing among 50-80-year-old prostate cancer patients
Helgason AR; Dickman PW; Adolfsson J; Steineck G
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 2000;3(1):37-42
Localized prostate cancer and 30 years of follow-up in a population-based setting
Adolfsson J; Oksanen H; Salo JO; Steineck G
Article: CLINICAL CANCER RESEARCH. 2000;6(2):610-615
Bladder cancer:: Allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade
Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
Article: UROLOGY. 1999;53(6):1252-1257
Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines
Morcos E; Jansson OT; Adolfsson J; Kratz G; Wiklund NP
Article: UROLOGY. 1999;53(5):945-950
Diagnostic value of percent free prostate-specific antigen:: Retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
Article: JOURNAL OF UROLOGY. 1999;161(2):505-508
Deferred treatment of locally advanced nonmetastatic prostate cancer: A long-term followup
Adolfsson J; Steineck G; Hedlund PO
Article: UROLOGY. 1998;52(6):1026-1029
Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis
Ehren I; Lundberg JON; Adolfsson J; Wiklund NP
Article: BRITISH JOURNAL OF CANCER. 1998;78(5):588-592
The role of nitric oxide in bacillus Calmette-Guerin mediated anti tumour effects in human bladder cancer
Jansson OT; Morcos E; Brundin L; Lundberg J; Adolfsson J; Söderhäll M; Wiklund NP
Article: JOURNAL OF UROLOGY. 1998;160(2):556-560
Nitric oxide synthase activity in human renal cell carcinoma
Jansson OT; Morcos E; Brundin L; Bergerheim USR; Adolfsson J; Wiklund NP
Article: PROSTATE CANCER AND PROSTATIC DISEASES. 1998;1(3):128-133
Distress due to unwanted side-effects of prostate cancer treatment is related to impaired well-being (quality of life)
Helgason AR; Adolfsson J; Dickman P; Fredrikson M; Steineck G
Article: EUROPEAN UROLOGY. 1998;33(1):11-16
Urinary and bowel symptoms in men with and without prostate cancer: Results from an observational study in the Stockholm area
Adolfsson J; Helgason AR; Dickman P; Steineck G
Article: BRITISH JOURNAL OF UROLOGY. 1998;81(1):135-141
'Potency': the validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability
Helgason AR; Arver S; Adolfsson J; Dickman P; Granath F; Steineck G
Article: UROLOGY. 1997;50(5):722-726
Deferred treatment of clinically localized low-grade prostate cancer: Actual 10-year and projected 15-year follow-up of the Karolinska series
Adolfsson J; Steineck G; Hedlund PO
Article: CANCER. 1997;80(4):748-752
Prostate carcinoma and long term survival
Adolfsson J; Rutqvist LE; Steineck G
Article: JOURNAL OF UROLOGY. 1997;158(1):155-159
Factors associated with waning sexual function among elderly men and prostate cancer patients
Helgason AR; Adolfsson J; Dickman P; Arver S; Fredrikson M; Steineck G
Article: UROLOGY. 1997;49(4A):27-38
Assessment of endpoints for clinical trials for localized prostate cancer
Schellhammer P; Cockett A; BocconGibod L; Gospodarowicz M; Krongrad A; Thompson IM; Scardino P; Soloway M; Adolfsson J
Article: UROLOGY. 1997;49(2):191-196
Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system
Meikle AW; Arver S; Dobs AS; Adolfsson J; Sanders SW; Middleton RG; Stephenson RA; Hoover DR; Rajaram L; Mazer NA
Article: UROLOGE. 1996;35(6):454-455
Deferred treatment of clinically localized prostate cancer. The Karolinska Hospital experience
Adolfsson J
Article: UROLOGY. 1996;48(5):700-702
Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis
Lundberg JON; Ehren I; Jansson O; Adolfsson J; Lundberg JM; Weitzberg E; Alving K; Wiklund NP
Article: AGE AND AGEING. 1996;25(4):285-291
Sexual desire, erection, orgasm and ejaculatory functions and their importance to elderly Swedish men: A population-based study
Helgason AR; Adolfsson J; Dickman P; Arver S; Fredrikson M; Gothberg M; Steineck G
Article: UROLOGY. 1996;48(1):105-109
Bias due to observation of different parts of a nonconstant hazard curve over time
Steineck G; Adolfsson J
Article: BRITISH JOURNAL OF CANCER. 1996;73(11):1417-1421
Waning sexual function - The most important disease-specific distress for patients with prostate cancer
Helgason A; Adolfsson J; Dickman P; Fredrikson M; Arver S; Steineck G
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1995;32(1):33-39
DECREASED SEXUAL CAPACITY AFTER EXTERNAL RADIATION-THERAPY FOR PROSTATE-CANCER IMPAIRS QUALITY-OF-LIFE
HELGASON AR; FREDERIKSON M; ADOLFSSON J; STEINECK G
Article: UROLOGY. 1995;45(4):610-615
DISTINGUISHING PROGNOSTIC AND TREATMENT-PREDICTIVE IN FORMATION FOR LOCALIZED PROSTATE-CANCER
STEINECK G; ADOLFSSON J; SCHER HI; WHITMORE WF
Article: UROLOGICAL RESEARCH. 1995;23(6):391-394
Modulation of smooth muscle activity by nitric oxide in the human upper urinary tract
Iversen HH; Ehren I; Gustafsson LE; Adolfsson J; Wiklund NP
Article: CANCER SURVEYS. 1995;23:141-148
RADICAL PROSTATECTOMY, RADIOTHERAPY OR DEFERRED TREATMENT FOR LOCALIZED PROSTATE-CANCER
ADOLFSSON J
Visa fler

Alla övriga publikationer

Review: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2023;112(11):2279-2292
A systematic review of hormone treatment for children with gender dysphoria and recommendations for research
Ludvigsson JF; Adolfsson J; Hoistad M; Rydelius P-A; Kristroem B; Landen M
Review: EUROPEAN RADIOLOGY. 2023;33(8):5258-5268
Magnetic resonance imaging of the knee for chronological age estimation-a systematic review
Muller L-SO; Adolfsson J; Forsberg L; Bring J; Dahlgren J; Domeij H; Gornitzki C; Wernersson E; Odeberg J
Editorial comment: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(3):213
Citing and endpoints
Adolfsson J
Editorial comment: ANNALS OF INTERNAL MEDICINE. 2022;175(5):735-739
Integrating Quality Assurance and Quality Improvement With Guidelines: Systematic Stakeholder-Driven Development of an Extension of the Guidelines International Network-McMaster Guideline Development Checklist
Piggott T; Langendam MW; Parmelli E; Adolfsson J; Akl EA; Armstrong D; Braithwaite J; Brignardello-Petersen R; Brozek J; Follmann M; Kopp I; Meerpohl JJ; Neamtiu L; Nothacker M; Qaseem A; Rossi PG; Saz-Parkinson Z; van der Wees PJ; Schunemann HJ
Review: BJS OPEN. 2021;5(2):zraa032
Routine versus selective intraoperative cholangiography during cholecystectomy: systematic review, meta-analysis and health economic model analysis of iatrogenic bile duct injury
Rystedt JML; Wiss J; Adolfsson J; Enochsson L; Hallerback B; Johansson P; Jonsson C; Leander P; Osterberg J; Montgomery A
Corrigendum: NATURE COMMUNICATIONS. 2019;10(1):382
Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)
Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Al Olama AA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu Y-J; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw K-T; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA; Henderson BE; Stern MC; Thwaites A; Guy M; Whitmore I; Morgan A; Fisher C; Hazel S; Livni N; Cook M; Fachal L; Weinstein S; Freeman LEB; Hoover RN; Machiela MJ; Lophatananon A; Carter BD; Goodman P; Moya L; Srinivasan S; Kedda M-A; Yeadon T; Eckert A; Eklund M; Cavalli-Bjoerkman C; Dunning AM; Sipeky C; Hakansson N; Elliott R; Ranu H; Giovannucci E; Turman C; Hunter DJ; Cussenot O; Orntoft TF; Lane A; Lewis SJ; Davis M; Key TJ; Brown P; Kulkarni GS; Zlotta AR; Fleshner NE; Finelli A; Mao X; Marzec J; MacInnis RJ; Milne R; Hopper JL; Aguado M; Bustamante M; Castano-Vinyals G; Gracia-Lavedan E; Cecchini L; Stampfer M; Ma J; Sellers TA; Geybels MS; Park H; Zachariah B; Kolb S; Wokolorczyk D; Lubinski J; Kluzniak W; Nielsen SF; Weisher M; Cuk K; Vogel W; Luedeke M; Logothetis CJ; Paulo P; Cardoso M; Maia S; Silva MP; Steele L; Ding YC; De Meerleer G; De Langhe S; Thierens H; Lim J; Tan MH; Ong AT; Lin DW; Kachakova D; Mitkova A; Mitev V; Parliament M; Jenster G; Bangma C; Schroder FH; Truong T; Koudou YA; Michael A; Kierzek A; Karlsson A; Broms M; Wu H; Aukim-Hastie C; Tillmans L; Riska S; McDonnell SK; Dearnaley D; Spurdle A; Gardiner R; Hayes V; Butler L; Taylor R; Papargiris M; Saunders P; Kujala P; Talala K; Taari K; Bentzen S; Hicks B; Vogt A; Hutchinson A; Cox A; George A; Toi A; Evans A; van der Kwast TH; Imai T; Saito S; Zhao S-C; Ren G; Zhang Y; Yu Y; Wu Y; Wu J; Zhou B; Pedersen J; Lobato-Busto R; Manuel Ruiz-Dominguez J; Mengual L; Alcaraz A; Pow-Sang J; Herkommer K; Vlahova A; Dikov T; Christova S; Carracedo A; Tretarre B; Rebillard X; Mulot C; Adolfsson J; Stattin P; Johansson J-E; Martin RM; Thompson IMJ; Chambers S; Aitken J; Horvath L; Haynes A-M; Tilley W; Risbridger G; Aly M; Nordstrom T; Pharoah P; Tammela TLJ; Murtola T; Auvinen A; Burnet N; Barnett G; Andriole G; Klim A; Drake BF; Borre M; Kerns S; Ostrer H; Zhang H-W; Cao G; Lin J; Ling J; Li M; Feng N; Li J; He W; Guo X; Sun Z; Wang G; Guo J; Southey MC; FitzGerald LM; Marsden G; Gomez-Caamano A; Carballo A; Peleteiro P; Calvo P; Szulkin R; Llorca J; Dierssen-Sotos T; Gomez-Acebo I; Lin H-Y; Ostrander EA; Bisbjerg R; Klarskov P; Roder MA; Iversen P; Holleczek B; Stegmaier C; Schnoeller T; Bohnert P; John EM; Ost P; Teo S-H; Gamulin M; Kulis T; Kastelan Z; Slavov C; Popov E; Van den Broeck T; Joniau S; Larkin S; Esteban Castelao J; Martinez ME; van Schaik RHN; Xu J; Lindstrom S; Riboli E; Berry C; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Freedman M; Cenee S; Sanchez M
Review: ECANCERMEDICALSCIENCE. 2018;12:802
A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
Crawley D; Chamberlain F; Garmo H; Rudman S; Zethelius B; Holmberg L; Adolfsson J; Stattin P; Carroll P; Van Hemelrijck M
Editorial comment: EUROPEAN UROLOGY FOCUS. 2017;3(6):526-528
Detection of Prostate Cancer Using a Multistep Approach with Prostate-specific Antigen, the Stockholm 3 Test, and Targeted Biopsies: The STHLM3 MRI Project
Nordstrom T; Picker W; Aly M; Jaderling F; Adolfsson J; Strom P; Haug ES; Eklund M; Carlsson S; Gronberg H
Letter: EUROPEAN UROLOGY. 2017;71(2):e61-e62
Re: Adi J. Klil-Drori, Hui Yin, Vicky Tagalakis, Armen Aprikian, Laurent Azoulay. Androgen Deprivation Therapy for Prostate Cancer and Risk of Venous Thromboembolism Eur Urol 2016;70:56-61
Van Hemelrijck M; Garmo H; Adolfsson J; Stattin P
Review: EUROPEAN UROLOGY. 2015;68(3):386-396
Quantifying Observational Evidence for Risk of Fatal and Nonfatal Cardiovascular Disease Following Androgen Deprivation Therapy for Prostate Cancer: A Meta-analysis
Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
Letter: THE BMJ. 2014;349:g7227
CERVICAL PRE-CANCER Using the term pre-cancer creates a new disease out of a risk factor reply
Strander B; Adolfsson J
Editorial comment: THE BMJ. 2014;349:g6611
Safety of modern treatment for cervical pre-cancer
Strander B; Adolfsson J
Review: BMJ SUPPORTIVE AND PALLIATIVE CARE. 2013;3(2):174-180
Quality indicators for palliative and end of life care: a review of Swedish policy documents.
Lind S; Adolfsson J; Axelsson B; Fürst CJ
Editorial comment: EUROPEAN UROLOGY. 2013;63(3):427
Reply from Authors re: Goutham Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:426-7 Changing Habits
Nordstrom T; Clements MS; Adolfsson J; Gronberg H
Letter: LAKARTIDNINGEN. 2013;110(5):227
[More randomized studies in health care can be made cheaper and more regularly].
Rosén M; Adolfsson J; Liliemark J; Vitols S
Editorial comment: EUROPEAN UROLOGY. 2012;61(4):703-704
Reply from Authors re: Matthew R. Cooperberg. Adverse Effects of Androgen Deprivation and the Limits of National Tumor Registries. Eur Urol 2012;61:701-3
Van Hemelrijck M; Stattin P; Adolfsson J
Letter: EUROPEAN UROLOGY. 2012;61(4):E28
Reply to Tommaso Cai, Carolina D'Elia, and Beatrice Detti's Letter to the Editor re: Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al. Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden. Eur Urol 2012;61:690-700
Van Hemelrijck M; Stattin P; Adolfsson J
Meeting abstract: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):324-325
NATION-WIDE POPULATION-BASED STUDY ON 15-YEAR MORTALITY IN PROSTATE CANCER ACCORDING TO RISK CATEGORIES IN THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN
Stattin P; Sandin F; Ahlgren G; Bratt O; Damber JE; Hugosson J; Pettersson B; Robinson D; Tornblom M; Karlsson S; Andren O; Bill-Axelson A; Widmark A; Egevad L; Ehrnstrom R; Adolfsson J; Lambe M; Johansson JE
Meeting abstract: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):337-338
ABSOLUTE AND RELATIVE RISK OF FRACTURES IN PROSTATE CANCER PATIENTS: RESULTS FROM THE POPULATION-BASED PCBASE SWEDEN
Adolfsson J; Thorstenson A; Bratt O; Hellborg H; Holmberg L; Lambe M; Bill-Axelson A; Stattin P
Meeting abstract: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):279
READMISSION AFTER RADICAL PROSTATECTOMY. NATION-WIDE, POPULATION-BASED STUDY IN PCBASE SWEDEN
Fridriksson J; Holmberg E; Bratt O; Garmo H; Adolfsson J; Lambe M; Bill-Axelson A; Stattin P
Meeting abstract: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):252-253
RISK PATTERNS OF FRACTURES AND CARDIOVASCULAR AND THROMBOEMBOLIC DISEASE, FOLLOWING PROSTATE CANCER TREATMENT: RESULTS FROM THE POPULATION-BASED PCBASE SWEDEN
Van Hemelrijck M; Garmo H; Holmberg H; Lambe M; Stattin P; Adolfsson J
Meeting abstract: EUROPEAN UROLOGY OPEN SCIENCE. 2011;10(2):239-240
MORTALITY AMONG MEN WITH LOCALLY ADVANCED PROSTATE CANCER MANAGED WITH NON-CURATIVE INTENT; A NATIONWIDE STUDY IN PCBASE SWEDEN
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Editorial comment: ACTA ONCOLOGICA. 2010;49(3):275-277
Screening for prostate cancer - will we ever know?
Adolfsson J
Meeting abstract: EJC SUPPLEMENTS. 2009;7(3):1
Increased cardiovascular morbidity and mortality following endocrine treatment for prostate cancer: an analysis in 30,642 men in PCBaSe Sweden
Van Hemelrijck M; Garmo H; Bratt O; Bill-Axelson A; Lambe M; Stattin P; Holmberg L; Adolfsson J
Editorial comment: EUROPEAN UROLOGY. 2009;55(5):1074
Editorial Comment on: Pharmacological Approaches to Reducing the Risk of Prostate Cancer
Adolfsson J
Editorial comment: EUROPEAN UROLOGY. 2009;55(2):525
Re: Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer: Part 2. Final Evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5
Adolfsson J
Review: BJU INTERNATIONAL. 2008;102(1):10-14
Watchful waiting and active surveillance: the current position
Adolfsson J
Editorial comment: EUROPEAN UROLOGY. 2008;54(1):16-18
The management of category T1a-T1b (incidental) prostate cancer: Can we predict who needs treatment?
Adolfsson J
Editorial comment: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2008;42(218):7-11
Chairmen's Summary
Andersson L; Droller MJ; Adolfsson J; Mansson W; Kirkali Z; Boffetta P; Montironi R; Malmstrom P-U; Tribukait B; Grossman HB
Editorial comment: NATURE REVIEWS UROLOGY. 2007;4(6):308-309
Can we define which patients with prostate cancer are suitable for expectant management?
Adolfsson J
Editorial comment: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2007;36(2):285-287
Commentary: On the incidence of histological prostate cancer and the probable diagnosis of cases with tumours too small to produce symptoms or to attract attention on physical examination - the findings of Dr Arnold Rice Rich
Adolfsson J
Review: PROSTATE. 2006;66(16):1729-1743
Systematic replication study of reported genetic associations in prostate cancer:: Strong support for genetic variation in the androgen pathway
Lindstrom S; Zheng SL; Wiklund F; Jonsson B-A; Adami H-O; Balter KA; Brookes AJ; Sun J; Chang B-L; Liu W; Li G; Isaacs WB; Adolfsson J; Gronberg H; Xu J
Editorial comment: NATURE REVIEWS UROLOGY. 2006;3(10):522-523
Individualized assessment of prostate cancer risk - Commentary
Adolfsson J
Editorial comment: NATURE REVIEWS UROLOGY. 2005;2(6):272-273
Do false-positive screening results affect screening behavior for prostate cancer?
Adolfsson J
Published conference paper: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2005;39(216):94-110
Epidemiology and statistical methods in prediction of patient outcome
Bostwick DG; Adolfsson J; Burke HB; Damber JE; Huland H; Pavone-Macaluso M; Waters DJ
Editorial comment: JOURNAL OF UROLOGY. 2005;174(6):2168
Editorial - Comment
Adolfsson J
Editorial comment: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2004;13(10):1677-1679
Interieukin-6 sequence variants are not associated with prostate cancer risk
Sun JL; Hedelin M; Zheng L; Adami HO; Bensen J; Augustsson-Bälter K; Chang BL; Adolfsson J; Adams T; Turner A; Meyers DA; Isaacs WB; Xu JF; Grönberg H
Review: BJU INTERNATIONAL. 2003;92(7):667-671
The clinical implications of the Prostate Cancer Prevention Trial
Marberger M; Adolfsson J; Borkowski A; Fitzpatrick J; Kirk D; Prezioso D; Rabaça C; Solsona E; Teillac P
Review: EUROPEAN UROLOGY. 2001;40(5):488-494
Active monitoring (deferred treatment or watchful waiting) in the treatment of prostate cancer - A review
Schmid HP; Adolfsson J; Aus G
Editorial comment: JOURNAL OF UROLOGY. 2001;166(3):962-963
Editorial: Quality of life
Adolfsson J
Published conference paper: PROSTATE CANCER AND PROSTATIC DISEASES. 2000;3(4):265-268
Prognostic and treatment predictive factors - is there a difference?
Adolfsson J; Steineck G
Review: LAKARTIDNINGEN. 2000;97(36):3870-3874
[Treatment of localized prostatic cancer--different alternatives. Patients with localized prostatic cancer must actively participate in the choice of therapy].
Adolfsson J
Published conference paper: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 2000;(205):44-49
Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract.
Häggman MJ; Adolfsson J; Khoury S; Montie JE; Norlén J
Published conference paper: EUROPEAN UROLOGY. 1999;36:3-8
The natural history of early prostate cancer and the impact of endocrine treatment
Adolfsson J
Review: EUROPEAN UROLOGY. 1998;33(6):513-522
Sexual dysfunction associated with the management of prostate cancer
Fitzpatrick JM; Kirby RS; Krane RJ; Adolfsson J; Newling DWW; Goldstein I
Review: PROSTATE CANCER AND PROSTATIC DISEASES. 1997;1(2):59-65
Conservative management of clinically localized prostate cancer
Adolfsson J
Review: INTERNATIONAL JOURNAL OF CANCER. 1996;:1-72
Mass screening for prostate cancer SBU - The Swedish Council on Technology Assessment in Health Care
Johansson JE; Abrahamsson PA; Adami HO; Adolfsson J; Carlsson P; Damber JE; Gustavsson O; Hallerby N; Landberg T; Marke LA; Norming U; Nyman CR; Ponten J; Rentzhog L; Vang J; Werko L; Jonsson E; Frodin JE; Hermeren G; Svardsudd K; Norlen BJ; Pettersson S; Hoisaeter PA; Gustafson R
Other: UROLOGY. 1995;46(5):631-637
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
ANDERSEN JT; EKMAN P; WOLF H; BEISLAND HO; JOHANSSON JE; KONTTURI M; LEHTONEN T; TVETER K; BODKER A; VEDEL O; NORDLING J; POULSEN AL; SCHOU J; HVIDT V; HANSEN JB; MEYHOFF HH; ELDRUP J; HARTWELL D; COLSTRUP H; LYNGDORF P; NIELSEN AH; LARSEN E; WALTER S; LARSEN EH; THYBO E; MOMMSEN S; BROK KE; PALM L; GENSTER H; ANDERSEN M; KAUPPINEN P; RAUVALA M; HAKKINEN J; TAMMELA T; TAINIO H; HYNNINEN O; TIITINEN J; LEHTORANTA K; ALAOPAS M; PERTTILA I; PETAS A; RINTALA E; SALMINEN R; JUUSELA H; HANSSON E; VONWENDT R; TUHKANEN K; TALJA M; NURMI M; PUNTALA P; PERMI J; PUOLAKKA VM; VIITANEN J; GISLASON T; EINARSSON GV; ERI LM; KARLSEN S; HOLME P; SIVERTSEN SM; STEINSVIK E; SERVOLL E; URNES T; MALME PA; JOHANSEN TEB; OMLAND H; NAGELHUS J; KLOSTER SE; SKJEGGESTAD O; VADA K; MORTENSEN R; NYBERG G; PETTERSSON G; WEDMAN L; BRATELL S; FOLMERZ P; ZACKRISSON B; DAHLGREN K; TILLEGARD A; AUS G; BERGDAHL S; HUGOSSON J; HOLMQUIST B; EK A; RADEMARK C; KRISTIANSEN P; HERMANSSON CG; PEDERSEN K; OSCARSSON C; KIHL B; OLSSON JO; NELVIN L; LEISSNER KH; LUNDSTAM S; HJERTBERG H; VARENHORST E; ANDERSSON SO; WINDAHL T; SWARTZ R; AHLBERG B; GEDDA S; ANDERSTROM C; EDDELAND S; HANSSON R; STROGERG P; ADOLFSSON J; BAUER P; KLEIST H; STORM B; RANCH T; STRAVSNES H; BREKKAN E; EKLUND T; KARLBERG L; MALICE MP; BRONEE V; WENNERLUND P; ERIKSSON LO; AASERUD E; LEHMUSSAARI J; SUOMIN R; GABRIEL MA
Review: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 1995;21(4):333-336
Deferred treatment for clinically localized prostate cancer.
Adolfsson J
Other: ACTA PHYSIOLOGICA. 1995;153(4):393-394
INDUCTION OF CALCIUM-DEPENDENT NITRIC-OXIDE SYNTHASE BY SEX-HORMONES IN THE GUINEA-PIG URINARY-BLADDER
EHREN I; HAMMARSTROM M; ADOLFSSON J; WIKLUND NP
Visa fler

Anställningar

Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, 1991

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI